{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fnhl-all-from-eha-icml-2025-0iB6gGNT","width":444,"version":"1.0","type":"rich","title":"Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/e814f008-43fb-4cea-b040-ef2e4d65d67b/101429-lymphoma-updates-eha-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/93ee17b1-2873-45a2-9fcf-2d4d0f5a4d67\" height=\"200\" width=\"100%\" title=\"Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, Max S. Topp, MD, and Pier Luigi Zinzani, MD, PhD, discuss their thoughts on a few of the most impactful studies in lymphomas and acute lymphoblastic leukemia (ALL) from the EHA and ICML 2025 congresses."}